These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 16625819)

  • 1. Pathological mechanisms involved in diabetic neuropathy: can we slow the process?
    Sima AA
    Curr Opin Investig Drugs; 2006 Apr; 7(4):324-37. PubMed ID: 16625819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 1 diabetic neuropathy and C-peptide.
    Sima AA; Zhang W; Grunberger G
    Exp Diabesity Res; 2004; 5(1):65-77. PubMed ID: 15198372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic neuropathy differs in type 1 and type 2 diabetes.
    Sima AA; Kamiya H
    Ann N Y Acad Sci; 2006 Nov; 1084():235-49. PubMed ID: 17151305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes.
    Sima AA; Kamiya H; Li ZG
    Eur J Pharmacol; 2004 Apr; 490(1-3):187-97. PubMed ID: 15094085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes.
    Kamiya H; Zhang W; Sima AA
    Ann Neurol; 2004 Dec; 56(6):827-35. PubMed ID: 15497155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats.
    Zhang W; Kamiya H; Ekberg K; Wahren J; Sima AA
    Diabetes Metab Res Rev; 2007 Jan; 23(1):63-70. PubMed ID: 16845685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-peptide and central nervous system complications in diabetes.
    Li ZG; Sima AA
    Exp Diabesity Res; 2004; 5(1):79-90. PubMed ID: 15198373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Perspective for the treatment of diabetic neuropathy: translation from molecular studies to bedside].
    Yagihashi S; Yamagishi S; Wada R
    Rinsho Shinkeigaku; 2005 Nov; 45(11):966-8. PubMed ID: 16447775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes.
    Kamiya H; Murakawa Y; Zhang W; Sima AA
    Diabetes Metab Res Rev; 2005; 21(5):448-58. PubMed ID: 15747389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered neurotrophism in diabetic neuropathy: spelunking the caves of peripheral nerve.
    Dobrowsky RT; Rouen S; Yu C
    J Pharmacol Exp Ther; 2005 May; 313(2):485-91. PubMed ID: 15608075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve growth factor and diabetic neuropathy.
    Pittenger G; Vinik A
    Exp Diabesity Res; 2003; 4(4):271-85. PubMed ID: 14668049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic neuropathy.
    Hayden MR; Tyagi SC
    Med Sci Monit; 2004 Dec; 10(12):RA291-307. PubMed ID: 15567993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics.
    Van Acker K; Bouhassira D; De Bacquer D; Weiss S; Matthys K; Raemen H; Mathieu C; Colin IM
    Diabetes Metab; 2009 Jun; 35(3):206-13. PubMed ID: 19297223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of diabetic neuropathy].
    Frati-Munari AC; Ariza-Andraca CR
    Gac Med Mex; 1998; 134(1):85-92. PubMed ID: 9658700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic neuropathies: unanswered questions.
    Harati Y
    Neurol Clin; 2007 Feb; 25(1):303-17. PubMed ID: 17324729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of neuropoietic cytokines in development and progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration.
    Skundric DS; Lisak RP
    Exp Diabesity Res; 2003; 4(4):303-12. PubMed ID: 14668051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diabetic neuropathies.
    Gooch C; Podwall D
    Neurologist; 2004 Nov; 10(6):311-22. PubMed ID: 15518597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Etiopathogenesis of diabetic neuropathy].
    Gryz EA; Galicka-Latała D; Szczudlik A; Sieradzki J
    Przegl Lek; 2000; 57(12):727-31. PubMed ID: 11398597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autonomic neuropathy in diabetic patients. Part I. Pathogenesis and clinical problems].
    Otto-Buczkowska E; Chobot PJ
    Pol Merkur Lekarski; 2002 Aug; 13(74):158-60. PubMed ID: 12420352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can diabetic neuropathy be prevented?
    Park TS; Park JH; Baek HS
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S53-6. PubMed ID: 15563981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.